About
Technology
Issues
FAQ
Links
Official Page
Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.